Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM

TO Goetze, RD Hofheinz, T Gaiser, H Schmalenberg, D Strumberg, E Goekkurt, S Angermeier, T Zander, HG Kopp, D Pink, Gabriele Siegler (Co-author), M Schenk, F de Vita, G Galizia, E Maiello, WO Bechstein, M Elshafei, M Loose, D Sookthai, T BrulinC Pauligk, N Homann, SE Al-Batran

Research output: Contribution to journalOriginal Articlepeer-review

8 Citations (Web of Science)
Original languageEnglish
JournalINTERNATIONAL JOURNAL OF CANCER
DOIs
Publication statusPublished - 2023

Keywords

  • GASTROESOPHAGEAL JUNCTION
  • GASTRIC-CANCER
  • DOUBLE-BLIND
  • OPEN-LABEL
  • MULTICENTER
  • THERAPY
  • CHEMOTHERAPY
  • RESECTION
  • BEVACIZUMAB
  • OXALIPLATIN

Cite this